{"transactions":[{"id":866975,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T18:47:26.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":54876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":54876,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":54876},"source":{"system":"sec-edgar","filing":"0001140361-26-007643","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036126007643/form4.xml","form_type":"4"}},{"id":1087343,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-07-15T16:22:57.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":11066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":11066,"derivative":{"exercise_price":0.59,"expiration_date":"2035-07-11","underlying":"Common Stock","underlying_shares":11066},"source":{"system":"sec-edgar","filing":"0001641172-25-019724","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000164117225019724/ownership.xml","form_type":"4"}},{"id":1114875,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-11T18:00:35.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":22700,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001140361-25-022224","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036125022224/form4.xml","form_type":"4"}},{"id":1235700,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Common Warrant","published_at":"2025-03-03T16:45:42.000Z","date":"2025-02-28","kind":"purchase","planned":false,"acquired":true,"shares":15060,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price for the Common Warrant is included in the purchase price for the shares of Common Stock reflected in Table I above."}],"balance_after":15060,"derivative":{"exercise_price":1.53,"exercise_date":"2025-02-28","expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":15060},"source":{"system":"sec-edgar","filing":"0001140361-25-006784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036125006784/form4.xml","form_type":"4"}},{"id":1235699,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-03T16:45:42.000Z","date":"2025-02-28","kind":"purchase","planned":false,"acquired":true,"shares":15060,"price":1.66,"value":24999.6,"ownership":{"direct":true},"balance_after":61213,"source":{"system":"sec-edgar","filing":"0001140361-25-006784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036125006784/form4.xml","form_type":"4"}},{"id":1451772,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-18T21:35:08.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option disclosed on this Form 4 was not previously reported due to an administrative oversight."},{"field":"shares","element":"transactionShares","label":"F2","text":"Share and dollar amounts give effect to the issuer's 1-for-35 reverse stock split effectuated on December 4, 2023, and 1-for-10 reverse stock split effectuated on April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests annually in three equal installments commencing on May 24, 2024."}],"balance_after":132,"derivative":{"exercise_price":152.46,"expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":132},"source":{"system":"sec-edgar","filing":"0001493152-24-028399","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000149315224028399/ownership.xml","form_type":"4"}},{"id":1469469,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-25T16:05:13.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":2.86,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-24-031294","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036124031294/form4.xml","form_type":"4"}},{"id":1489100,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-06T20:49:24.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":false,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective June 4, 2024, the Board of Directors accelerated the vesting of outstanding  and unvested equity totaling 11, 904  shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Effective June 4, 2024, the Board of Directors accelerated the vesting of outstanding  and unvested equity totaling 11, 904  shares of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000805928-24-000075","document":"wk-form4_1717706957.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000075/wk-form4_1717706957.xml","form_type":"4"}},{"id":1489099,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:49:24.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Effective June 4, 2024, the Board of Directors accelerated the vesting of outstanding  and unvested equity totaling 11, 904  shares of common stock."}],"balance_after":283498,"source":{"system":"sec-edgar","filing":"0000805928-24-000075","document":"wk-form4_1717706957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000075/wk-form4_1717706957.xml","form_type":"4"}},{"id":1588063,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-08T22:31:19.000Z","date":"2024-03-07","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":9,"value":225000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.95 to $9.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":271594,"source":{"system":"sec-edgar","filing":"0000805928-24-000039","document":"wk-form4_1709937069.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000039/wk-form4_1709937069.xml","form_type":"4"}},{"id":1786360,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-09-07T10:28:11.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."}],"balance_after":11904,"derivative":{"underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000805928-23-000112","document":"wf-form4_169408247926456.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000112/wf-form4_169408247926456.xml","form_type":"4"}},{"id":1786359,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2023-09-07T10:28:11.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":20436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."}],"balance_after":20436,"derivative":{"exercise_price":6.3,"expiration_date":"2033-09-01","underlying":"Common Stock","underlying_shares":20436},"source":{"system":"sec-edgar","filing":"0000805928-23-000112","document":"wf-form4_169408247926456.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000112/wf-form4_169408247926456.xml","form_type":"4"}},{"id":1828625,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-17T17:30:12.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":5.13,"expiration_date":"2033-07-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-23-034839","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036123034839/form4.xml","form_type":"4"}},{"id":1868345,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-05T22:47:34.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year from the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year from the anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000805928-23-000062","document":"wf-form4_168600524446062.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000062/wf-form4_168600524446062.xml","form_type":"4"}},{"id":1868344,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T22:47:34.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This reflects the number of restricted stock units that vested on June 1, 2023."}],"balance_after":296594,"source":{"system":"sec-edgar","filing":"0000805928-23-000062","document":"wf-form4_168600524446062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000062/wf-form4_168600524446062.xml","form_type":"4"}},{"id":1868343,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T22:47:34.000Z","date":"2023-06-01","kind":"sale","planned":false,"acquired":false,"shares":29480,"price":8.74,"value":257655.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.66 to $8.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":290135,"source":{"system":"sec-edgar","filing":"0000805928-23-000062","document":"wf-form4_168600524446062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000062/wf-form4_168600524446062.xml","form_type":"4"}},{"id":1868342,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T22:47:34.000Z","date":"2023-06-01","kind":"sale","planned":false,"acquired":false,"shares":12500,"price":8.65,"value":108125.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.57 to $8.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":319615,"source":{"system":"sec-edgar","filing":"0000805928-23-000062","document":"wf-form4_168600524446062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000062/wf-form4_168600524446062.xml","form_type":"4"}},{"id":1880450,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T20:12:53.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":4640,"price":9.26,"value":42966.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.21 to $9.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":332115,"source":{"system":"sec-edgar","filing":"0000805928-23-000056","document":"wf-form4_168495914913321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000056/wf-form4_168495914913321.xml","form_type":"4"}},{"id":1880449,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T20:12:53.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":2828,"price":9.17,"value":25932.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.15 to $9.20 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":336755,"source":{"system":"sec-edgar","filing":"0000805928-23-000056","document":"wf-form4_168495914913321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000056/wf-form4_168495914913321.xml","form_type":"4"}},{"id":2115409,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-16T21:05:35.000Z","date":"2022-11-14","kind":"sale","acquired":false,"shares":13000,"price":12.74,"value":165620.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.51 to $13.07 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":339583,"source":{"system":"sec-edgar","filing":"0000805928-22-000121","document":"wf-form4_166863270834343.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000121/wf-form4_166863270834343.xml","form_type":"4"}},{"id":2120548,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:09:34.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":13000,"price":12.5,"value":162500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":352583,"source":{"system":"sec-edgar","filing":"0000805928-22-000119","document":"wf-form4_166811453210822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000119/wf-form4_166811453210822.xml","form_type":"4"}},{"id":2188624,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-12T01:50:04.000Z","date":"2022-08-10","kind":"sale","acquired":false,"shares":8886,"price":9.696,"value":86158.656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.50 to $9.99 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":365583,"source":{"system":"sec-edgar","filing":"0000805928-22-000107","document":"wf-form4_166026898857805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000107/wf-form4_166026898857805.xml","form_type":"4"}},{"id":2192423,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-08T21:49:51.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":13046,"price":10.37,"value":135287.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"The reported price in Colum 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging for $10.15 to $10.72 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote,"}],"balance_after":374469,"source":{"system":"sec-edgar","filing":"0000805928-22-000105","document":"wf-form4_165999536701295.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000105/wf-form4_165999536701295.xml","form_type":"4"}},{"id":2192422,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-08T21:49:51.000Z","date":"2022-08-04","kind":"sale","acquired":false,"shares":24000,"price":10.64,"value":255360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.35 to $10.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":387515,"source":{"system":"sec-edgar","filing":"0000805928-22-000105","document":"wf-form4_165999536701295.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000105/wf-form4_165999536701295.xml","form_type":"4"}},{"id":2202318,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2022-07-27T00:42:57.000Z","date":"2022-07-25","kind":"exercise","acquired":false,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.38,"exercise_date":"2016-05-26","expiration_date":"2022-08-06","underlying":"Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0000805928-22-000098","document":"wf-form4_165888256034498.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000098/wf-form4_165888256034498.xml","form_type":"4"}},{"id":2202317,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-27T00:42:57.000Z","date":"2022-07-25","kind":"tax_withholding","acquired":false,"shares":30296,"price":9.26,"value":280540.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 83,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 52,704 shares of common stock."}],"balance_after":411515,"source":{"system":"sec-edgar","filing":"0000805928-22-000098","document":"wf-form4_165888256034498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000098/wf-form4_165888256034498.xml","form_type":"4"}},{"id":2202316,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-27T00:42:57.000Z","date":"2022-07-25","kind":"exercise","acquired":true,"shares":83000,"price":3.38,"value":280540.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 83,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 52,704 shares of common stock."}],"balance_after":441811,"source":{"system":"sec-edgar","filing":"0000805928-22-000098","document":"wf-form4_165888256034498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000098/wf-form4_165888256034498.xml","form_type":"4"}},{"id":2219361,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T16:15:42.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":3.9,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-22-024465","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036122024465/form4.xml","form_type":"4"}},{"id":2246222,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-03T20:06:33.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":6459,"derivative":{"underlying":"Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000805928-22-000062","document":"wf-form4_165428677346545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000062/wf-form4_165428677346545.xml","form_type":"4"}},{"id":2246221,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2022-06-03T20:06:33.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":11811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":11811,"derivative":{"exercise_price":9.29,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":11811},"source":{"system":"sec-edgar","filing":"0000805928-22-000062","document":"wf-form4_165428677346545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000062/wf-form4_165428677346545.xml","form_type":"4"}},{"id":2246220,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-03T20:06:33.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3036},"source":{"system":"sec-edgar","filing":"0000805928-22-000062","document":"wf-form4_165428677346545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000062/wf-form4_165428677346545.xml","form_type":"4"}},{"id":2246219,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:06:33.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on June 1, 2022."}],"balance_after":358811,"source":{"system":"sec-edgar","filing":"0000805928-22-000062","document":"wf-form4_165428677346545.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000062/wf-form4_165428677346545.xml","form_type":"4"}},{"id":2662320,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2021-06-21T20:17:56.000Z","date":"2021-06-17","kind":"exercise","acquired":false,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on December 27, 2022 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":19.17,"expiration_date":"2028-12-27","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0000805928-21-000121","document":"wf-form4_162430665353712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000121/wf-form4_162430665353712.xml","form_type":"4"}},{"id":2662319,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T20:17:56.000Z","date":"2021-06-17","kind":"tax_withholding","acquired":false,"shares":8781,"price":20.92,"value":183698.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Of the 8,781 reported shares, 8,477 shares were swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule 16b-3. Additionally, 304 shares of common stock were surrendered to satisfy the reporting person's tax withholding liability. In total, the reporting person received 469 additional shares of common stock."}],"balance_after":355775,"source":{"system":"sec-edgar","filing":"0000805928-21-000121","document":"wf-form4_162430665353712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000121/wf-form4_162430665353712.xml","form_type":"4"}},{"id":2662318,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T20:17:56.000Z","date":"2021-06-17","kind":"exercise","acquired":true,"shares":9250,"price":19.17,"value":177322.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Of the 8,781 reported shares, 8,477 shares were swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule 16b-3. Additionally, 304 shares of common stock were surrendered to satisfy the reporting person's tax withholding liability. In total, the reporting person received 469 additional shares of common stock."}],"balance_after":364556,"source":{"system":"sec-edgar","filing":"0000805928-21-000121","document":"wf-form4_162430665353712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000121/wf-form4_162430665353712.xml","form_type":"4"}},{"id":2663713,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T18:45:33.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in full and become fully exercisable on June 17, 2022."}],"balance_after":9000,"derivative":{"exercise_price":9.95,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-21-021489","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036121021489/form4.xml","form_type":"4"}},{"id":2663712,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-17T18:45:33.000Z","date":"2021-06-15","kind":"purchase","acquired":true,"shares":5882,"price":8.5,"value":49997.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on June 17, 2021, and such shares of common stock are subject to a lock up agreement between the Reporting Person and Cantor Fitzgerald & Co., pursuant to which the shares cannot be sold for 90 days following June 15, 2021."}],"balance_after":46153,"source":{"system":"sec-edgar","filing":"0001140361-21-021489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036121021489/form4.xml","form_type":"4"}},{"id":2678416,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-08T20:25:19.000Z","date":"2021-06-04","kind":"exercise","acquired":false,"shares":24000,"price":3.67,"value":88080.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares pursuant to the employee stock option will became vested on December 29, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares each 6 months thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All shares pursuant to the employee stock option will became vested on December 29, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares each 6 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.67,"expiration_date":"2021-12-29","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000805928-21-000118","document":"wf-form4_162318390357941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000118/wf-form4_162318390357941.xml","form_type":"4"}},{"id":2678415,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T20:25:19.000Z","date":"2021-06-04","kind":"exercise","acquired":true,"shares":24000,"price":3.67,"value":88080.0,"ownership":{"direct":true},"balance_after":355306,"source":{"system":"sec-edgar","filing":"0000805928-21-000118","document":"wf-form4_162318390357941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000118/wf-form4_162318390357941.xml","form_type":"4"}},{"id":2684912,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-03T21:13:45.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":3036,"derivative":{"underlying":"Common Stock","underlying_shares":3036},"source":{"system":"sec-edgar","filing":"0000805928-21-000110","document":"wf-form4_162275480526647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000110/wf-form4_162275480526647.xml","form_type":"4"}},{"id":2684911,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2021-06-03T21:13:45.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":6030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":6030,"derivative":{"exercise_price":19.76,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":6030},"source":{"system":"sec-edgar","filing":"0000805928-21-000110","document":"wf-form4_162275480526647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000110/wf-form4_162275480526647.xml","form_type":"4"}},{"id":2692260,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2021-05-28T20:05:58.000Z","date":"2021-05-26","kind":"exercise","acquired":false,"shares":50000,"price":8.95,"value":447500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":8.95,"expiration_date":"2026-12-29","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000805928-21-000099","document":"wf-form4_162223233198745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000099/wf-form4_162223233198745.xml","form_type":"4"}},{"id":2692259,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2021-05-28T20:05:58.000Z","date":"2021-05-26","kind":"exercise","acquired":false,"shares":15000,"price":5.45,"value":81750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares of Common Stock underlying the employee stock option became fully vested on December 31, 2016. The option vested in two equal installments beginning on September 30, 2016, and became fully vested on December 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":5.45,"expiration_date":"2023-05-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000805928-21-000099","document":"wf-form4_162223233198745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000099/wf-form4_162223233198745.xml","form_type":"4"}},{"id":2692258,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2021-05-28T20:05:58.000Z","date":"2021-05-26","kind":"exercise","acquired":false,"shares":6000,"price":5.45,"value":32700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of Common Stock underlying the employee stock option became fully vested on May 26, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on May 26, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vested  each 6 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":5.45,"expiration_date":"2023-05-26","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000805928-21-000099","document":"wf-form4_162223233198745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000099/wf-form4_162223233198745.xml","form_type":"4"}},{"id":2692257,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2021-05-28T20:05:58.000Z","date":"2021-05-26","kind":"exercise","acquired":false,"shares":9000,"price":5.09,"value":45810.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2019 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2016 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":5.09,"expiration_date":"2022-12-29","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000805928-21-000099","document":"wf-form4_162223233198745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000099/wf-form4_162223233198745.xml","form_type":"4"}},{"id":2692256,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2021-05-28T20:05:58.000Z","date":"2021-05-26","kind":"exercise","acquired":false,"shares":22954,"price":3.67,"value":84241.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.67,"expiration_date":"2021-12-29","underlying":"Common Stock","underlying_shares":22954},"source":{"system":"sec-edgar","filing":"0000805928-21-000099","document":"wf-form4_162223233198745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000099/wf-form4_162223233198745.xml","form_type":"4"}},{"id":2692255,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T20:05:58.000Z","date":"2021-05-26","kind":"exercise","acquired":true,"shares":50000,"price":8.95,"value":447500.0,"ownership":{"direct":true},"balance_after":331306,"source":{"system":"sec-edgar","filing":"0000805928-21-000099","document":"wf-form4_162223233198745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000099/wf-form4_162223233198745.xml","form_type":"4"}},{"id":2692254,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T20:05:58.000Z","date":"2021-05-26","kind":"exercise","acquired":true,"shares":15000,"price":5.45,"value":81750.0,"ownership":{"direct":true},"balance_after":281306,"source":{"system":"sec-edgar","filing":"0000805928-21-000099","document":"wf-form4_162223233198745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000099/wf-form4_162223233198745.xml","form_type":"4"}},{"id":2692253,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T20:05:58.000Z","date":"2021-05-26","kind":"exercise","acquired":true,"shares":6000,"price":5.45,"value":32700.0,"ownership":{"direct":true},"balance_after":266306,"source":{"system":"sec-edgar","filing":"0000805928-21-000099","document":"wf-form4_162223233198745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000099/wf-form4_162223233198745.xml","form_type":"4"}},{"id":2692252,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T20:05:58.000Z","date":"2021-05-26","kind":"exercise","acquired":true,"shares":9000,"price":5.09,"value":45810.0,"ownership":{"direct":true},"balance_after":260306,"source":{"system":"sec-edgar","filing":"0000805928-21-000099","document":"wf-form4_162223233198745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000099/wf-form4_162223233198745.xml","form_type":"4"}},{"id":2692251,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T20:05:58.000Z","date":"2021-05-26","kind":"exercise","acquired":true,"shares":22954,"price":3.67,"value":84241.18,"ownership":{"direct":true},"balance_after":251306,"source":{"system":"sec-edgar","filing":"0000805928-21-000099","document":"wf-form4_162223233198745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000099/wf-form4_162223233198745.xml","form_type":"4"}},{"id":2828174,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-01T21:08:52.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":24000,"price":22.06,"value":529440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.56 to $22.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4."}],"balance_after":228352,"source":{"system":"sec-edgar","filing":"0000805928-21-000046","document":"wf-form4_161463290842472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000046/wf-form4_161463290842472.xml","form_type":"4"}},{"id":2852431,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T22:16:39.000Z","date":"2021-02-17","kind":"tax_withholding","acquired":false,"shares":545,"price":18.7,"value":10191.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 16, 2021."}],"balance_after":252352,"source":{"system":"sec-edgar","filing":"0000805928-21-000024","document":"wf-form4_161368656384787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000024/wf-form4_161368656384787.xml","form_type":"4"}},{"id":2852430,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T22:16:39.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":1784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 16, 2021 upon the attainment of certain performance criteria."}],"balance_after":252897,"source":{"system":"sec-edgar","filing":"0000805928-21-000024","document":"wf-form4_161368656384787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000024/wf-form4_161368656384787.xml","form_type":"4"}},{"id":2852429,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T22:16:39.000Z","date":"2021-02-17","kind":"tax_withholding","acquired":false,"shares":1032,"price":18.7,"value":19298.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 16, 2021."}],"balance_after":251113,"source":{"system":"sec-edgar","filing":"0000805928-21-000024","document":"wf-form4_161368656384787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000024/wf-form4_161368656384787.xml","form_type":"4"}},{"id":2852428,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T22:16:39.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":3377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 16, 2021 upon the attainment of certain performance criteria."}],"balance_after":252145,"source":{"system":"sec-edgar","filing":"0000805928-21-000024","document":"wf-form4_161368656384787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000024/wf-form4_161368656384787.xml","form_type":"4"}},{"id":2929705,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T17:53:07.000Z","date":"2020-12-29","kind":"sale","acquired":false,"shares":916,"price":17.81,"value":16313.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units granted on December 27, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":248345,"source":{"system":"sec-edgar","filing":"0001179110-20-012293","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020012293/edgar.xml","form_type":"4"}},{"id":2929704,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T17:53:07.000Z","date":"2020-12-27","kind":"grant","acquired":true,"shares":2300,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of December 27, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This reflects the number of restricted stock units that became vested as of December 27, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1885 shares acquired under the Axogen, Inc. employee stock purchase plan on June 30, 2020."}],"balance_after":249261,"source":{"system":"sec-edgar","filing":"0001179110-20-012293","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020012293/edgar.xml","form_type":"4"}},{"id":2935467,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T20:15:41.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":379,"price":16.42,"value":6223.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units granted on December 18, 2020. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":245076,"source":{"system":"sec-edgar","filing":"0001179110-20-012171","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020012171/edgar.xml","form_type":"4"}},{"id":2935466,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T20:15:41.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":925,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of December 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This reflects the number of restricted stock units that became vested as of December 18, 2020."}],"balance_after":245455,"source":{"system":"sec-edgar","filing":"0001179110-20-012171","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020012171/edgar.xml","form_type":"4"}},{"id":3029392,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-17T20:57:03.000Z","date":"2020-09-15","kind":"exercise","acquired":false,"shares":4046,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22954,"derivative":{"exercise_price":3.67,"exercise_date":"2014-12-29","expiration_date":"2021-12-29","underlying":"Common Stock","underlying_shares":4046},"source":{"system":"sec-edgar","filing":"0001179110-20-009860","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020009860/edgar.xml","form_type":"4"}},{"id":3029391,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-17T20:57:03.000Z","date":"2020-09-15","kind":"exercise","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24000,"derivative":{"exercise_price":3.67,"exercise_date":"2014-12-29","expiration_date":"2021-12-29","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001179110-20-009860","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020009860/edgar.xml","form_type":"4"}},{"id":3029390,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-17T20:57:03.000Z","date":"2020-09-15","kind":"exercise","acquired":true,"shares":13046,"price":3.67,"value":47878.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the cash exercise of stock options for a total of 13,046 shares."}],"balance_after":244530,"source":{"system":"sec-edgar","filing":"0001179110-20-009860","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020009860/edgar.xml","form_type":"4"}},{"id":3099740,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-25T18:43:28.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the option shall vest upon each of the first, second, and third anniversaries of the date of grant, such that the option will be fully vested on June 23, 2023."}],"balance_after":9000,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-20-014773","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036120014773/form4.xml","form_type":"4"}},{"id":3129809,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-06-01T11:08:02.000Z","date":"2020-05-29","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.5,"exercise_date":"2010-06-01","expiration_date":"2020-06-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001179110-20-006736","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020006736/edgar.xml","form_type":"4"}},{"id":3129808,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-06-01T11:08:02.000Z","date":"2020-05-29","kind":"exercise","acquired":true,"shares":125000,"price":3.5,"value":437500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1. This Form is being filed to report the cash exercise of a stock option for a total of 125,000 shares."}],"balance_after":231484,"source":{"system":"sec-edgar","filing":"0001179110-20-006736","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020006736/edgar.xml","form_type":"4"}},{"id":3203632,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2020-03-18T21:15:19.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of Axogen Inc. common stock underlying the restricted stock Units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All shares of Axogen Inc. common stock underlying the restricted stock Units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":12000,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-20-003912","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020003912/edgar.xml","form_type":"4"}},{"id":3203631,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2020-03-18T21:15:19.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2024 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":24000,"derivative":{"exercise_price":8.61,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001179110-20-003912","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020003912/edgar.xml","form_type":"4"}},{"id":3261022,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-02-20T18:19:38.000Z","date":"2020-02-18","kind":"tax_withholding","acquired":false,"shares":529,"price":14.68,"value":7765.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 18, 2020."}],"balance_after":106484,"source":{"system":"sec-edgar","filing":"0001179110-20-001944","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020001944/edgar.xml","form_type":"4"}},{"id":3261021,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-02-20T18:19:38.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":1783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 18, 2020 upon the attainment of certain performance criteria."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This reflects the number of shares that became vested as of February 18, 2020 upon the attainment of certain performance criteria."}],"balance_after":107013,"source":{"system":"sec-edgar","filing":"0001179110-20-001944","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020001944/edgar.xml","form_type":"4"}},{"id":3261020,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-02-20T18:19:38.000Z","date":"2020-02-18","kind":"tax_withholding","acquired":false,"shares":1002,"price":14.68,"value":14709.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 18, 2020."}],"balance_after":105230,"source":{"system":"sec-edgar","filing":"0001179110-20-001944","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020001944/edgar.xml","form_type":"4"}},{"id":3261019,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-02-20T18:19:38.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":3377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 18, 2020 upon the attainment of certain performance criteria."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This reflects the number of shares that became vested as of February 18, 2020 upon the attainment of certain performance criteria."}],"balance_after":106232,"source":{"system":"sec-edgar","filing":"0001179110-20-001944","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020001944/edgar.xml","form_type":"4"}},{"id":3263200,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-19T16:31:05.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":38400,"price":1.3,"value":49920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on February 14, 2020."}],"balance_after":40271,"source":{"system":"sec-edgar","filing":"0001140361-20-003647","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036120003647/form4.xml","form_type":"4"}},{"id":3334614,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-12-20T21:16:37.000Z","date":"2019-12-18","kind":"tax_withholding","acquired":false,"shares":567,"price":16.73,"value":9485.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of the restricted stock units that vested on December 18, 2019."}],"balance_after":101543,"source":{"system":"sec-edgar","filing":"0001179110-19-013082","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911019013082/edgar.xml","form_type":"4"}},{"id":3334613,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-12-20T21:16:37.000Z","date":"2019-12-18","kind":"grant","acquired":true,"shares":1850,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of December 18, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This reflects the number of restricted stock units that became vested as of December 18, 2019."}],"balance_after":102110,"source":{"system":"sec-edgar","filing":"0001179110-19-013082","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911019013082/edgar.xml","form_type":"4"}},{"id":3474693,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-01T16:35:51.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the option shall vest upon each of the first, second, and third anniversaries of the date of grant, such that the option will be fully vested on June 28, 2022."}],"balance_after":9000,"derivative":{"exercise_price":5.99,"expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001127602-19-023223","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000112760219023223/form4.xml","form_type":"4"}},{"id":3651954,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-02-19T18:25:41.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":3377,"price":17.57,"value":59333.89,"ownership":{"direct":true},"balance_after":100260,"source":{"system":"sec-edgar","filing":"0001179110-19-002058","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911019002058/edgar.xml","form_type":"4"}},{"id":3716546,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2018-12-31T21:37:28.000Z","date":"2018-12-27","kind":"grant","acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":4600,"derivative":{"underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0001179110-18-014322","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018014322/edgar.xml","form_type":"4"}},{"id":3716545,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2018-12-31T21:37:28.000Z","date":"2018-12-27","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on December 27, 2022 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":18500,"derivative":{"exercise_price":19.17,"expiration_date":"2028-12-27","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001179110-18-014322","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018014322/edgar.xml","form_type":"4"}},{"id":3745037,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2018-12-05T00:30:47.000Z","date":"2018-11-30","kind":"sale","acquired":false,"shares":45000,"price":33,"value":1485000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the \"Plan\") adopted by the reporting person on September 7, 2018, as amended November 9, 2018.  The sales resulted in the completion of the Plan so no more shares will be sold pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the actual sale price for all of these shares that were sold in multiple transactions. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the sale of the shares."}],"balance_after":95865,"source":{"system":"sec-edgar","filing":"0001179110-18-013429","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018013429/edgar.xml","form_type":"4"}},{"id":3763936,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2018-11-15T22:16:46.000Z","date":"2018-11-15","kind":"sale","acquired":false,"shares":20000,"price":32.25,"value":645000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.51. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":140865,"source":{"system":"sec-edgar","filing":"0001179110-18-012899","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018012899/edgar.xml","form_type":"4"}},{"id":3984497,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2018-03-23T12:44:59.000Z","date":"2018-03-21","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.81,"exercise_date":"2015-01-02","expiration_date":"2021-01-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001179110-18-004789","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018004789/edgar.xml","form_type":"4"}},{"id":3984496,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2018-03-23T12:44:59.000Z","date":"2018-03-21","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.46,"exercise_date":"2014-10-01","expiration_date":"2021-10-01","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001179110-18-004789","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018004789/edgar.xml","form_type":"4"}},{"id":3984495,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Common Stock","published_at":"2018-03-23T12:44:59.000Z","date":"2018-03-21","kind":"tax_withholding","acquired":false,"shares":1874,"price":38.5,"value":72149.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 31,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 28,104 shares of common stock."}],"balance_after":160865,"source":{"system":"sec-edgar","filing":"0001179110-18-004789","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018004789/edgar.xml","form_type":"4"}},{"id":3984494,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Common Stock","published_at":"2018-03-23T12:44:59.000Z","date":"2018-03-21","kind":"exercise","acquired":true,"shares":15000,"price":4.81,"value":72150.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 31,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 28,104 shares of common stock."}],"balance_after":162739,"source":{"system":"sec-edgar","filing":"0001179110-18-004789","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018004789/edgar.xml","form_type":"4"}},{"id":3984493,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Common Stock","published_at":"2018-03-23T12:44:59.000Z","date":"2018-03-21","kind":"tax_withholding","acquired":false,"shares":1022,"price":38.5,"value":39347.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 31,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 28,104 shares of common stock."}],"balance_after":147739,"source":{"system":"sec-edgar","filing":"0001179110-18-004789","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018004789/edgar.xml","form_type":"4"}},{"id":3984492,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Common Stock","published_at":"2018-03-23T12:44:59.000Z","date":"2018-03-21","kind":"exercise","acquired":true,"shares":16000,"price":2.46,"value":39360.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 31,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 28,104 shares of common stock."}],"balance_after":148761,"source":{"system":"sec-edgar","filing":"0001179110-18-004789","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018004789/edgar.xml","form_type":"4"}},{"id":4018022,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2018-03-05T22:27:39.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.74,"exercise_date":"2015-12-26","expiration_date":"2018-12-26","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001179110-18-003516","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018003516/edgar.xml","form_type":"4"}},{"id":4018021,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Common Stock","published_at":"2018-03-05T22:27:39.000Z","date":"2018-03-01","kind":"tax_withholding","acquired":false,"shares":2905,"price":33.95,"value":98624.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 36,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,095 shares of common stock."}],"balance_after":132761,"source":{"system":"sec-edgar","filing":"0001179110-18-003516","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018003516/edgar.xml","form_type":"4"}},{"id":4018020,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Common Stock","published_at":"2018-03-05T22:27:39.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":36000,"price":2.74,"value":98640.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 36,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,095 shares of common stock."}],"balance_after":135666,"source":{"system":"sec-edgar","filing":"0001179110-18-003516","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018003516/edgar.xml","form_type":"4"}},{"id":4125561,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Restricted Stock Units","published_at":"2017-12-20T23:55:15.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":3700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":3700,"derivative":{"underlying":"Common Stock","underlying_shares":3700},"source":{"system":"sec-edgar","filing":"0001179110-17-015746","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017015746/edgar.xml","form_type":"4"}},{"id":4125560,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2017-12-20T23:55:15.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":22100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on December 18, 2021 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":22100,"derivative":{"exercise_price":27,"expiration_date":"2027-12-18","underlying":"Common Stock","underlying_shares":22100},"source":{"system":"sec-edgar","filing":"0001179110-17-015746","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017015746/edgar.xml","form_type":"4"}},{"id":4201232,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2017-09-27T21:22:34.000Z","date":"2017-09-25","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36000,"derivative":{"exercise_price":2.74,"exercise_date":"2015-12-26","expiration_date":"2018-12-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-17-012731","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017012731/edgar.xml","form_type":"4"}},{"id":4201231,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Common Stock","published_at":"2017-09-27T21:22:34.000Z","date":"2017-09-25","kind":"tax_withholding","acquired":false,"shares":1450,"price":18.9,"value":27405.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 10,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 8,550 shares of common stock."}],"balance_after":99666,"source":{"system":"sec-edgar","filing":"0001179110-17-012731","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017012731/edgar.xml","form_type":"4"}},{"id":4201230,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Common Stock","published_at":"2017-09-27T21:22:34.000Z","date":"2017-09-25","kind":"exercise","acquired":true,"shares":10000,"price":2.74,"value":27400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 10,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 8,550 shares of common stock."}],"balance_after":101116,"source":{"system":"sec-edgar","filing":"0001179110-17-012731","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017012731/edgar.xml","form_type":"4"}},{"id":4223014,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2017-08-29T20:58:19.000Z","date":"2017-08-27","kind":"exercise","acquired":false,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46000,"derivative":{"exercise_price":2.74,"exercise_date":"2015-12-26","expiration_date":"2018-12-26","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001179110-17-011880","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017011880/edgar.xml","form_type":"4"}},{"id":4223013,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Common Stock","published_at":"2017-08-29T20:58:19.000Z","date":"2017-08-27","kind":"tax_withholding","acquired":false,"shares":3785,"price":16.65,"value":63020.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 23,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 19,215 shares of common stock."}],"balance_after":91116,"source":{"system":"sec-edgar","filing":"0001179110-17-011880","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017011880/edgar.xml","form_type":"4"}},{"id":4223012,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Common Stock","published_at":"2017-08-29T20:58:19.000Z","date":"2017-08-27","kind":"exercise","acquired":true,"shares":23000,"price":2.74,"value":63020.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form is being filed to report the exercise of a stock option for a total of 23,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 19,215 shares of common stock."}],"balance_after":94901,"source":{"system":"sec-edgar","filing":"0001179110-17-011880","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017011880/edgar.xml","form_type":"4"}},{"id":4387471,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2017-03-14T23:31:38.000Z","date":"2017-12-30","kind":"exercise","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":69000,"derivative":{"exercise_price":2.74,"exercise_date":"2015-12-26","expiration_date":"2018-12-26","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001179110-17-004608","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017004608/edgar.xml","form_type":"4"}},{"id":4387470,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP BD"}}],"security":"Common Stock","published_at":"2017-03-14T23:31:38.000Z","date":"2016-12-30","kind":"exercise","acquired":true,"shares":23000,"price":2.74,"value":63020.0,"ownership":{"direct":true},"balance_after":71901,"source":{"system":"sec-edgar","filing":"0001179110-17-004608","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017004608/edgar.xml","form_type":"4"}}],"next_cursor":"2017-03-14T23:31:38.000000Z,4387470"}